Physician profile
Gary L Steinbrook
NPI 1750341616
$327.82
in general payments reported to CMS, 2019-2025
8 companies · $78.09 in 2025
The $78.09 reported for 2025 was less than what a typical Sports Medicine (Family Medicine) provider received nationally (typical 2025 total: $113).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $59.99 · 2021: $12.67 · 2022: $15.45 · 2023: $111 · 2024: $50.95 · 2025: $78.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $240.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $239.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $80.61 | 2020-2023 | Rybelsus, Ozempic |
| Dexcom, INC. | $69.34 | 2024-2025 | Dexcom G6 Transmitter |
| Astellas Pharma US INC | $57.74 | 2023-2024 | Veozah |
| Glaxosmithkline, LLC. | $50.70 | 2020-2023 | Trelegy Ellipta |
| E.R. Squibb & Sons, L.L.C. | $32.20 | 2025 | Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.67 | 2021 | |
| Merck Sharp & Dohme LLC | $12.31 | 2020 | |
| Lilly USA, LLC | $12.25 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Steinbrook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.